Spero Therapeutics Inc
NASDAQ:SPRO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Spero Therapeutics Inc
NASDAQ:SPRO
|
US |
|
T
|
Talkspace Inc
NASDAQ:TALK
|
US |
|
Protalix Biotherapeutics Inc
F:PBDA
|
US |
|
V
|
Vinci SA
OTC:VCISY
|
FR |
|
F
|
Financiera Independencia SAB de CV SOFOM ENR
BMV:FINDEP
|
MX |
|
Tamburi Investment Partners SpA
MIL:TIP
|
IT |
|
N
|
NVR Inc
F:NVE
|
US |
|
D
|
Daiwa House Industry Co Ltd
XBER:DWH
|
JP |
|
A
|
American Express Co
XHAM:AEC1
|
US |
|
Arca Continental SAB de CV
OTC:EMBVF
|
MX |
|
ING Groep NV
MIL:1INGA
|
NL |
|
Sekisui House Ltd
F:SPH1
|
JP |
|
Prospect Capital Corp
NASDAQ:PSEC
|
US |
|
Shenandoah Telecommunications Co
NASDAQ:SHEN
|
US |
|
Western Union Co
NYSE:WU
|
US |
|
China Securities Co Ltd
F:CS0
|
CN |
|
A
|
Airbus SE
MAD:AIR
|
NL |
|
I
|
Infineon Technologies AG
DUS:IFX
|
DE |
|
Ingersoll Rand Inc
NYSE:IR
|
US |
|
AltaGas Ltd
TSX:ALA
|
CA |
|
L
|
Lagardere SA
XHAM:LAG
|
FR |
|
Gerard Perrier Industrie SA
F:80T
|
FR |
|
FAP Agri Tbk PT
IDX:FAPA
|
ID |
|
Ryan Specialty Group Holdings Inc
NYSE:RYAN
|
US |
Bankruptcy Probability
Spero Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Spero Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Spero Therapeutics Inc
NASDAQ:SPRO
|
159.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Spero Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Spero Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
